peoplePerson
Natasha B. Leighl
Lung cancer oncologist who showed plasma genotyping matches tissue and leads Canadian lung trials.
Led the NILE study validating plasma cfDNA genotyping in NSCLC and numerous Canadian Cancer Trials Group lung studies; past IASLC president.
Role
Lung Site Lead, Medical Oncology; OSI Pharmaceuticals Foundation Chair in Cancer New Drug Development
Institution
Specialisms
Lung cancerLiquid biopsyHealth economics
Profiles
| Title | Journal | Year |
|---|---|---|
| Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non-small cell lung cancer | Clinical Cancer Research | 2019 |
Pages like this
not linked directly; found by shared links- PersonLillian L. Siu
Shares Princess Margaret Cancer Centre, Liquid biopsy (ctDNA).
- PersonTrevor J. Pugh
Shares Princess Margaret Cancer Centre, Liquid biopsy (ctDNA).
- PersonDaniel A. Haber
- PersonCharu Aggarwal
- PersonMaximilian Diehn
- PersonAsh A. Alizadeh
- InstitutionQueen Mary Hospital / University of Hong Kong
- InstitutionHealthCare Global Enterprises